GE HealthCare Technologies Inc. (BIT:1GEHC)

Market Cap	28.74B
Revenue (ttm)	17.00B
Net Income (ttm)	1.91B
Shares Out	n/a
EPS (ttm)	4.16
PE Ratio	15.07
Forward PE	15.99
Dividend	0.03 (0.05%)
Ex-Dividend Date	Jul 24, 2025

Volume	n/a
Average Volume	17
Open	60.49
Previous Close	60.49
Day's Range	60.49 - 60.49
52-Week Range	60.05 - 66.15
Beta	n/a
RSI	23.09
Earnings Date	Jul 30, 2025

About Ligand Pharmaceuticals

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided ther...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2022
• Employees: 53,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1GEHC

Financial Performance

In 2024, BIT:1GEHC's revenue was $19.67 billion, an increase of 0.61% compared to the previous year's $19.55 billion. Earnings were $1.99 billion, an increase of 43.90%.